Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000902664-23-003397
Filing Date
2023-06-02
Accepted
2023-06-02 16:56:50
Documents
2

Document Format Files

Seq Description Document Type Size
1 TSCAN THERAPEUTICS, INC.. p23-1699sc13g.htm SC 13G 62779
2 JOINT FILING AGREEMENT p23-1699exhibit_99.htm EX-99 4397
  Complete submission text file 0000902664-23-003397.txt   68702
Mailing Address 880 WINTER STREET WALTHAM MA 02451
Business Address 880 WINTER STREET WALTHAM MA 02451 857-399-9500
TScan Therapeutics, Inc. (Subject) CIK: 0001783328 (see all company filings)

EIN.: 825282075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92700 | Film No.: 23989844
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 151 CALLE DE SAN FRANCISCO SUITE 200 PMB 1237 SAN JUAN PR 00901-1607
Business Address 151 CALLE DE SAN FRANCISCO SUITE 200 PMB 1237 SAN JUAN PR 00901-1607 703-963-7214
Lynx1 Capital Management LP (Filed by) CIK: 0001910456 (see all company filings)

EIN.: 851134656 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G